BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Vanguard Morningstar Growth ETF
VUG
$225B
| $8.24M | ﹤0.01% |
172,302
-28,386
| -14% | -$1.29M |
|
3652
Telkom Indonesia
TLK
$15B
| $8.21M | ﹤0.01% |
378,825
-29,356
| -7% | -$679K |
|
|
AFCG
3653
AFC Gamma
AFCG
$62.7M
| $8.18M | ﹤0.01% |
+578,829
| New | +$8.93M |
|
3654
Summit Therapeutics
SMMT
$10.4B
| $8.17M | ﹤0.01% |
1,095,147
+348,045
| +47% | +$2.28M |
|
3655
BlackRock Short Maturity Municipal Bond ETF
MEAR
$1.36B
| $8.16M | ﹤0.01% |
162,663
-12,773
| -7% | -$641K |
|
3656
Willis Lease Finance
WLFC
$1.74B
| $8.16M | ﹤0.01% |
571,017
-44,886
| -7% | -$655K |
|
3657
Disc Medicine
IRON
$2.93B
| $8.14M | ﹤0.01% |
41,920
+33,877
| +421% | +$11.1M |
|
3658
Orchestra BioMed
OBIO
$247M
| $8.13M | ﹤0.01% |
797,348
-2,652
| -0.3% | -$27.4K |
|
|
MBII
3659
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $8.13M | ﹤0.01% |
4,895,602
+1,345,859
| +38% | +$2.25M |
|
3660
Fresenius Medical Care
FMS
$13.6B
| $8.11M | ﹤0.01% |
194,952
+23,410
| +14% | +$936K |
|
3661
Fathom Holdings
FTHM
$27.7M
| $8.08M | ﹤0.01% |
246,439
-8,964
| -4% | -$295K |
|
|
EXPR
3662
DELISTED
Express, Inc.
EXPR
| $8.03M | ﹤0.01% |
61,891
-184,801
| -75% | -$15.6M |
|
|
KLDO
3663
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $8M | ﹤0.01% |
1,075,022
+64,659
| +6% | +$458K |
|
3664
Neuropace
NPCE
$460M
| $7.96M | ﹤0.01% |
+334,495
| New | +$7.76M |
|
|
SRTA
3665
Strata Critical Medical Inc
SRTA
$480M
| $7.95M | ﹤0.01% |
+756,871
| New | +$7.47M |
|
3666
Verrica Pharmaceuticals
VRCA
$90.2M
| $7.94M | ﹤0.01% |
70,284
+161
| +0.2% | +$19.5K |
|
|
GENI.WS
3667
DELISTED
Genius Sports Limited Redeemable Warrants, each whole warrant exercisable for one Ordinary Share each at an exercise price of $11. 50 per share
GENI.WS
| $7.94M | ﹤0.01% |
+1,000,000
| New | +$8.35M |
|
3668
Aurinia Pharmaceuticals
AUPH
$1.87B
| $7.92M | ﹤0.01% |
610,991
-491,997
| -45% | -$6.27M |
|
|
PMBC
3669
DELISTED
Pacific Mercantile Bancorp
PMBC
| $7.9M | ﹤0.01% |
918,839
-60,435
| -6% | -$527K |
|
|
SMED
3670
DELISTED
Sharps Compliance Corp
SMED
| $7.89M | ﹤0.01% |
765,585
-34,542
| -4% | -$481K |
|
|
PAMT
3671
PAMT Corp
PAMT
$349M
| $7.82M | ﹤0.01% |
593,224
-210,008
| -26% | -$3.04M |
|
3672
Bioventus
BVS
$913M
| $7.75M | ﹤0.01% |
440,134
+48,308
| +12% | +$778K |
|
3673
MoonLake Immunotherapeutics
MLTX
$1.48B
| $7.74M | ﹤0.01% |
747,863
-2,290
| -0.3% | -$23.3K |
|
3674
AST SpaceMobile
ASTS
$19B
| $7.74M | ﹤0.01% |
+598,147
| New | +$5.39M |
|
3675
Western New England Bancorp
WNEB
$263M
| $7.7M | ﹤0.01% |
944,223
-1,496,627
| -61% | -$12.4M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.